Clinical Trials Browser

Phase 2 × Unknown × Non-squamous Non-small Cell Lung Cancer × Clear all

NCT05394233 2022-05-27

Tislelizumab +Bevacizumab+pc for Untreated EGFR+ and High PD-L1 Non-squamous NSCLC

Phase 2 Unknown

Non-squamous Non-small Cell Lung Cancer

NCT03127319 2018-01-17

A Study of Apatinib Plus Docetaxel for Treatment of Advanced Non-squamous Non-small Cell Lung Cancer With Bone Metastases

Phase 2 Unknown

Non-squamous Non-small Cell Lung Cancer